 Shares of Aethlon Medical Inc. skyrocketed more than fourfold on massive volume toward a two-year high in morning trading Wednesday, even though the California-based therapeutic technology company hasnt released any news in nearly a week. On June 3, the company pointed out a pre-print manuscript that has not yet completed peer review that was published in Research Square, highlighting case studies of two critically ill COVID-19 patients who were given access to the companys Hemopurifier through Emergency Use. 